Literature DB >> 18684798

Evaluation of in-vivo animal and in-vitro models for prediction of dermal absorption in man.

I Jakasa1, S Kezic.   

Abstract

Risk assessment of dermal exposure to chemicals requires percutaneous absorption data to link the external exposure to the systemic uptake. The most reliable data on percutaneous absorption are obtained from in-vivo human volunteer studies. In addition to ethical constrains, the conduct of these studies is not feasible for the large number of industrial chemicals in use today. Therefore, there is an increasing need for alternative methods to determine percutaneous absorption such as in-vitro assays and methods performed in vivo in experimental animals. In this article, recent comparative in-vitro and in-vivo studies on percutaneous absorption have been addressed with emphasis on the factors that may affect the predictive value of the in-vitro models. Furthermore, the use of animal models, in particular the rat skin, in prediction of percutaneous absorption in the human skin has been reviewed. In-vitro assays showed to be largely influenced by the experimental circumstances, such as type and thickness of the skin, receptor fluid, and the way in which percutaneous absorption is calculated. Rat skin showed consistently to be more permeable than human skin. However, the difference between human and rat skin does not show a consistent pattern between chemicals hampering prediction of human percutaneous absorption. To increase predictive value of in-vitro and animal models, the influence of experimental factors on the percutaneous absorption should be systematically investigated by comparison with human in-vivo data, resulting in more prescriptive guidelines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684798     DOI: 10.1177/0960327107085826

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  8 in total

1.  Estimation of human percutaneous bioavailability for two novel brominated flame retardants, 2-ethylhexyl 2,3,4,5-tetrabromobenzoate (EH-TBB) and bis(2-ethylhexyl) tetrabromophthalate (BEH-TEBP).

Authors:  Gabriel A Knudsen; Michael F Hughes; J Michael Sanders; Samantha M Hall; Linda S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  2016-10-11       Impact factor: 4.219

2.  Vehicle type affects filling of fractional laser-ablated channels imaged by optical coherence tomography.

Authors:  Uffe Høgh Olesen; Mette Mogensen; Merete Haedersdal
Journal:  Lasers Med Sci       Date:  2017-02-17       Impact factor: 3.161

3.  Pharmacokinetics and the Dermal Absorption of Bromochlorophene, a Cosmetic Preservative Ingredient, in Rats.

Authors:  Yong-Jae Lee; Hyang-Yeon Kim; Quynh-Lien Pham; Jung-Dae Lee; Kyu-Bong Kim
Journal:  Toxics       Date:  2022-06-16

Review 4.  Progress and future of in vitro models to study translocation of nanoparticles.

Authors:  Hedwig M Braakhuis; Samantha K Kloet; Sanja Kezic; Frieke Kuper; Margriet V D Z Park; Susann Bellmann; Meike van der Zande; Séverine Le Gac; Petra Krystek; Ruud J B Peters; Ivonne M C M Rietjens; Hans Bouwmeester
Journal:  Arch Toxicol       Date:  2015-05-15       Impact factor: 5.153

5.  Can models of percutaneous absorption based on in vitro data in frogs predict in vivo absorption?

Authors:  Victoria K Llewelyn; Lee Berger; Beverley D Glass
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240

Review 6.  Towards bioinspired in vitro models of intestinal mucus.

Authors:  Lorenzo Sardelli; Daniela Peneda Pacheco; Anna Ziccarelli; Marta Tunesi; Omar Caspani; Andrea Fusari; Francesco Briatico Vangosa; Carmen Giordano; Paola Petrini
Journal:  RSC Adv       Date:  2019-05-21       Impact factor: 4.036

7.  An open-access data set of pig skin anatomy and physiology for modelling purposes.

Authors:  Laura Krumpholz; James F Clarke; Sebastian Polak; Barbara Wiśniowska
Journal:  Database (Oxford)       Date:  2022-10-08       Impact factor: 4.462

Review 8.  In vitro toxicity model: Upgrades to bridge the gap between preclinical and clinical research.

Authors:  Eneko Madorran; Andraž Stožer; Sebastjan Bevc; Uroš Maver
Journal:  Bosn J Basic Med Sci       Date:  2020-05-01       Impact factor: 3.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.